Politics heats up on the murder of pregnant Hathini, Wayanad MP Rahul

In Kerala, politics has started to heat up after the murder of a pregnant Hathini under a conspiracy. A series of charges and counter-allegations have also started between the two major parties of the country, BJP and Congress. The BJP has directly targeted Rahul Gandhi.

The attack on behalf of the party is commanded by Union Minister Smriti Irani. Expressing outrage over the incident of Hathini's murder, he put Congress MP Rahul Gandhi from Wayanad in Kerala in the dock.

Irani said condolences are not expected from Rahul. If Rahul Gandhi did not care about humans in Amethi, then what would he care about animals in Kerala. Irani said that the feelings of the nation had played out.

Let me tell you that in the Silent Valley Forest, a pregnant elephant was killed by feeding a pineapple full of crackers. His body was recovered from a pond.

Maneka Gandhi is also a target

On Wednesday, Union Minister Maneka Gandhi called the incident a murder and asked Rahul what action has been taken so far in the death of Hathini. Maneka said that Kerala is the most violent state in the country. Here people throw poison on the streets so that 300 to 400 birds and dogs die simultaneously.

Congress retaliated

Whereas in this case, the Congress defended Rahul Gandhi and said that he is being unnecessarily surrounded on this matter. What happened in Kerala is very sad.

Strict action will be taken against the guilty - Javadekar

Union Environment Minister Prakash Javadekar said that we will leave no stone unturned to properly investigate and apprehend the culprits. It is not Indian culture to kill animals with firecrackers. Strict action will be taken against the culprits. The central government has taken Hathini's death seriously in Kerala.

Exclusive Interview: Working with Narendra Modi is a crooked task: Manoj Tiwari

New Delhi / Team Digital. Manoj Tiwari is feeling very light after losing the post of Delhi BJP President. Tiwari, forgetting the family and the village in the politics of Delhi, shared his heart in an exclusive interview to Punjab Kesari Group. He said that being the state president during the Narendra Modi era is a big thing in itself.

During this time a lot was learned. He said that now he will increase his services more than before and will work better under the leadership of Adesh Gupta.

In a special interview, Manoj Tiwari openly shared about the factionalism in the party, his experience of three and a half years in the party and the strategy ahead. Watch full interview: -

Good news: got corona virus medicine Japan gave permission to use.

Los Angeles: A biotech company from California, California, states that its experimental drug Remedisivir saw improvement in symptoms when given to five-day-old, hospitalized patients from Covid-19 to moderately ill, Covid-19 has gone.

This medicine is injected into the vein. It has been approved to treat Kovid-19 patients in Japan. In the US also it has been allowed to give some patients in emergency.

Gilead Sciences gave some details on Monday, but said that full results will be published soon in the medical journal.

In experiments, Remedicivir has emerged as a drug that is expected to help fight the incurable disease of this coronavirus.

A large study, led by the National Institutes of Health, was conducted which found that this drug reduces the average duration of recovery for critically ill hospitalized patients. This medicine reduces the days of recovery from 15 to 11 days.

About 600 patients were studied under the leadership of the company. He had mild pneumonia but did not need oxygen. All were given medicines randomly for five to 10 days, with normal care taken.

Gilead said that on the 11th day of the study, patients who had been given Remedicivir for five days were 65 percent more likely to improve, on at least one on a seven-point scale. These include measures such as need for treatment and breathing machine.

Ten days of treatment did not prove to be better than standard care alone.

None of the patients who were given medication for five days died, while two of those who gave medicine for 10 days died and only four of those receiving standard care died. However, the complaints of nausea and headache were slightly higher among those taking this medicine.

Infectious disease specialist Dr. Radha Rajasingham at the University of Minnesota Medical Center pointed out that the study has some limitations but there is a controlled group that helps to verify that remedicivir has some benefits.